SPOTLIGHT -
Breakthroughs are changing the physicians treatment approach
Dynamic range of focus recovery in presbyopes after laser scleral microporation
Laser scleral microporation rejuvenates dynamic range of focus by increasing scleral pliability, allowing underlying structures to move more freely
Novel Therapies in Neovascular AMD and DME: Achieving Superior Anatomic Outcomes with Fewer Injections
Gonioscopy-assisted transluminal trabeculotomy (GATT) offers relief for patients undergoing corneal transplant
The approach to lowering intraocular pressure reduces medication burden without risking graft rejection
Long-Term Efficacy and Durability of Latest Therapies in neovascular AMD and DMO
Distorted corneas: How to regularise them with minimally invasive surgery
Sequential customised therapeutic keratectomy (SCTK) improves visual quality by eliminating superficial corneal high order aberrations
US FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis
Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents
